The IBC is managed by the Office of Sponsored Projects. The contact email address is OSP@LIU.edu
In accordance with the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, Long Island University maintains an Institutional Biosafety Committee (IBC).
The IBC is responsible for reviewing and overseeing research that involves recombinant or synthetic nucleic acid molecules as well as other potentially biohazardous materials.
Recombinant nucleic acid molecules are defined as genetic material constructed outside of living cells by joining DNA or RNA segments from different sources, while synthetic nucleic acid molecules are those that are chemically or otherwise artificially synthesized. Those recombinant or synthetic molecules are often called recombinant DNA, or rDNA for short.
Biohazardous materials more broadly include microorganisms (like viruses or bacteria), human- or animal-derived materials (like blood or tumor cells), and other biological agents and toxins that may pose risks to health or the environment.
These technologies and materials are central to modern biological and biomedical research. They enable the study of diseases, gene functions and regulation, as well as the development of novel therapeutics and diagnostic tools. Because such work carries specific biosafety considerations, the IBC provides institutional oversight to uphold safe and responsible research practices, protect laboratory personnel and the broader community, and ensure compliance with applicable federal regulations and institutional policies.
The IBC meets semi-annually, or more frequently based on IBC protocol submissions. An IBC protocol which is submitted into the online protocol system will be pre-reviewed by the IBC office within 7 days. Once the IBC protocol is review-ready, it will be sent to the full IBC committee to be reviewed at a convened meeting. This review typically happens within 30 days of submission of a review-ready protocol.
If you are unsure if your research requires an IBC protocol, an IBC Determination Form can be completed and submitted to the IBC office for review. Please contact the IBC office regarding this determination form.
CITI training is required for IBC submissions. The courses which must be completed are listed below.
Instructions for CITI:
At LIU, the IRBManager platform is used for IBC protocol submission. The link to the platform:
On the dashboard, you will find a box "Click here to start an IBC Application", click on that box and the IBC protocol will open.
For any IBC questions, or assistance with the IRBManager platform, contact the Office of Sponsored Projects at OSP@LIU.edu